BAALC and acute myeloid leukemia: miR-3151, described more recently, was not included in this previous study; its particular location, within a BAALC intron, a well-known AML prognostic factor,35 and its prognostic impact observed in an elderly AML cohort, prompted us to analyze its expression and prognostic effect in younger IR-AML patients.